Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 29, 2022

A panhaemocytometric approach to COVID-19: the importance of cell population data on Sysmex XN-series analysers in severe disease

  • James V. Harte ORCID logo EMAIL logo , Caoimhe Ní Choileáin , Conor Grieve , Carmel Hooton and Vitaliy Mykytiv ORCID logo EMAIL logo

Corresponding authors: Mr. James V. Harte, Scientific Lead, and Dr. Vitaliy Mykytiv, Clinical Lead, Haematology Department, Cork University Hospital, Cork, Ireland, E-mail: (J. V. Harte), (V. Mykytiv)
James V. Harte and Caoimhe Ní Choileáin contributed equally to this work.

Acknowledgments

The authors would like to acknowledge the Haematology Department at Cork University Hospital, in particular Medical Laboratory Scientists, for encouragement, discussion, and support throughout this study. The authors would also like to gratiously thank Mr. Bradley Williams for technical support.

  1. Research funding: None declared.

  2. Author contributions: J.V. Harte, and V. Mykytiv conceptualized the study, designed the methodology, and were responsible for project administration; C. Grieve and C. Hooton were responsible for haemocytometric and microbiological data extraction; J.V. Harte and C.Ní Choileáin were responsible for data curation and formal analysis; J.V. Harte wrote the original manuscript. J.V. Harte revised the manuscript for final publication. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: All volunteers who donated blood for the determination of haemocytometric reference intervals provided informed consent.

  5. Ethical approval: The study protocol for the determination of haemocytometric reference intervals was approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals (reference number: ECM4(a) 9/3/2021 – COVID 19). The retrospective review of anonymised data was also approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals (reference number: ECM4(e) 9/2/2021 – COVID 19). The retrospective review of anonymised data based on haemocytometric and microbiological data extracted from the Laboratory Information System did not require informed consent, in accordance with approval by the Clinical Research Ethics Committee of the Cork Teaching Hospitals.

  6. Data availability: The full dataset of haemocytometric parameters in patients with COVID-19, including all cell population data (CPD) parameters, is available from the authors upon reasonable request.

References

1. World Health Organisation. WHO coronavirus (COVID-19) dashboard [Online]. Available from: https://covid19.who.int/ [Accessed 6 Nov 2022].Search in Google Scholar

2. Harte, JV, Mykytiv, V. A panhaemocytometric approach to COVID-19: a retrospective study on the importance of monocyte and neutrophil population data on Sysmex XN-series analysers. Clin Chem Lab Med 2021;59:E169–72. https://doi.org/10.1515/cclm-2021-0096.Search in Google Scholar PubMed

3. Martens, RJH, van Adrichem, AJ, Mattheij, NJA, Brouwer, CG, van Twist, DJL, Broerse, JJCR, et al.. Hemocytometric characteristics of COVID-19 patients with and without cytokine Storm syndrome on the Sysmex XN-10 hematology analyzer. Clin Chem Lab Med 2020;59:783–93. https://doi.org/10.1515/cclm-2020-1529.Search in Google Scholar PubMed

4. Linssen, J, Ermens, A, Berrevoets, M, Seghezzi, M, Previtali, G, van der Sar-van der Brugge, S, et al.. A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study. Elife 2020;9:1–37. https://doi.org/10.7554/eLife.63195.Search in Google Scholar PubMed PubMed Central

5. Horn, PS, Pesce, AJ. Reference intervals: an update. Clin Chim Acta 2003;334:5–23. https://doi.org/10.1016/S0009-8981(03)00133-5.Search in Google Scholar

6. Horowitz, GL, Altaie, S, Boyd, JC, Ceriotti, F, Garg, U, Horn, P, et al.. EP28-A3c: Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, 3rd ed Pennsylvania: Clinical and Laboratory Standards Institute; 2010.Search in Google Scholar

7. van Pelt, JL, Klatte, S, Hwandih, T, Barcaru, A, Riphagen, IJ, Linssen, J, et al.. Reference intervals for Sysmex XN hematological parameters as assessed in the Dutch Lifelines cohort. Clin Chem Lab Med 2022;60:907–20. https://doi.org/10.1515/CCLM-2022-0094/DOWNLOADASSET/SUPPL/J_CCLM-2022-0094_SUPPL_002.XLSX.Search in Google Scholar

8. Junqueira, C, Crespo, Â, Ranjbar, S, de Lacerda, LB, Lewandrowski, M, Ingber, J, et al.. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 2022;606:7914: 2022;606:576–84. https://doi.org/10.1038/s41586-022-04702-4.Search in Google Scholar PubMed

9. Urrechaga, E, Aguirre, U, España, PP, de Guadiana, LG. Complete blood counts and cell population data from Sysmex XN analyser in the detection of SARS-CoV-2 infection. Clin Chem Lab Med 2021;59:e57–60. https://doi.org/10.1515/cclm-2020-1416.Search in Google Scholar PubMed

10. Parthasarathi, A, Padukudru, S, Arunachal, S, Basavaraj, CK, Krishna, MT, Ganguly, K, et al.. The role of neutrophil-to-lymphocyte ratio in risk stratification and prognostication of COVID-19: a Systematic Review and Meta-Analysis. Vaccines 2022;10. https://doi.org/10.3390/VACCINES10081233/S1.Search in Google Scholar

Received: 2022-10-22
Accepted: 2022-11-17
Published Online: 2022-11-29
Published in Print: 2023-02-23

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-1066/html
Scroll to top button